Related Experiment Videos
A follow-up study of patients with implantable cardioverter defibrillators
Insights
Implantable cardioverter defibrillators (ICDs) effectively prevent sudden cardiac death (SCD) in high-risk patients. This study shows high survival rates and low complication rates with ICDs over a 9-year follow-up period.
Area of Science:
- Cardiology
- Medical Devices
- Electrophysiology
Background:
- Serious ventricular dysrhythmias pose a significant risk of sudden cardiac death.
- Implantable cardioverter defibrillators (ICDs) are a key therapeutic option for managing these life-threatening arrhythmias.
- Long-term outcomes and complication profiles of ICDs require ongoing evaluation.
Purpose of the Study:
- To evaluate the long-term effectiveness of implantable cardioverter defibrillators (ICDs) in preventing sudden cardiac death (SCD).
- To assess the complication rates associated with ICD implantation and shock delivery.
- To describe patient characteristics and shock experiences in a large cohort.
Main Methods:
- Prospective follow-up of 381 patients who received an implantable cardioverter defibrillator (ICD).
- Data collection on survival, device efficacy, shock events, and complications over a period of up to 9 years.
- Categorization of delivered shocks into appropriate, indeterminate, and inappropriate events.
Main Results:
- ICDs demonstrated significant efficacy in preventing sudden cardiac death (SCD), with 5-year survival rates reaching 94%.
- Overall complication rates were reported as low.
- A total of 225 patients received shocks, averaging 2.3 shocks per patient year, with detailed analysis of shock categories provided.
Conclusions:
- Implantable cardioverter defibrillators (ICDs) are a safe and effective strategy for managing serious ventricular dysrhythmias and reducing mortality.
- The study confirms the life-saving benefits of ICDs, supporting their continued use in appropriate patient populations.
- Understanding shock characteristics is crucial for optimizing ICD therapy and patient management.
Abstract:
This study involves 381 patients who received an implantable cardioverter defibrillator (ICD) for management of serious ventricular dysrhythmias and were followed for up to 9 years. The device was effective in preventing sudden cardiac death (SCD), with survival rates of 97% at 3 years and 94% at 5 years. Complication rates were low. Two hundred and twenty-five patients received at least one shock; 2.3 shocks per patient year were received. Shocks were categorized as appropriate, indeterminate, or inappropriate. Definitions of these categories and their occurrence are discussed and the characteristics and experiences of these patients are described.